Merck KGaA (MKGAY.PK) News Headlines

▮ More

Date

Headline

11/21/2022 8:28:04 AM Merck KGaA Aims To Launch One New Product Or Major Indication Every 1.5 Years On Average

11/21/2022 8:08:29 AM Merck KGaA Aims To Launch One New Product Or Indication Every 1.5 Years

11/10/2022 1:41:44 AM Merck Reports Increased Profit, Sales For Q3; Updates Sales Outlook

11/10/2022 1:02:31 AM Merck KGaA Q3 Group Net Sales Rise By 16.8% To EUR 5.8 Bln

10/6/2022 3:35:39 AM Merck Group Says On Track To Hit EUR 25 Bln Sales Target By 2025

10/6/2022 2:37:39 AM Merck KGaA Reaffirms Growth Objectives; Plans Larger-scale Acquisitions An Option From 2023 Onwards

8/31/2022 8:22:39 AM Guardant Health Expands Collaboration With Merck KGaA

8/31/2022 8:12:21 AM Guardant Health Expands Collaboration With Merck KGaA On Oncology Therapeutics

8/4/2022 1:20:51 AM Merck KGaA Q2 Profit Rises, Lifts FY22 Forecast, Backs Organic Growth View - Quick Facts

8/4/2022 1:01:54 AM Merck KGaA Q2 Group Net Sales Rise By 14.3% To EUR 5.6 Bln

5/23/2022 7:22:32 AM Merck KGaA To Invest Around EUR 440 Mln To Boost Two Life Science Projects In Ireland

5/23/2022 6:14:57 AM Merck KGaA To Invest EUR 440 Mln In Two Major Life Science Projects In Ireland Over Five Years

5/12/2022 1:19:53 AM Merck KGaA Q1 Profit Rises; Specifies FY22 Forecast For Earnings, Sales - Quick Facts

5/12/2022 1:02:38 AM Merck KGaA Q1 Group Sales Up 12.2% To EUR 5.2 Bln

3/3/2022 1:31:44 AM Merck Group FY21 EBITDA Pre Rises; Net Sales Up 13.8% Organically

3/3/2022 1:01:50 AM Merck KGaA FY Sales Up 12.3% To EUR 19.7 Bln

1/5/2022 8:49:16 AM F-star Therapeutics : Merck KGaA Exercises Fourth Licensing Option In Immuno-Oncology Collaboration

12/30/2021 2:37:06 AM Merck Gets Multi-year, 121 Mln Euros Contract From U.S. Govt.

12/17/2021 8:22:58 AM Merck KGaA: TEPMETKO Receives CHMP Positive Opinion In Adult Patients With Advanced NSCLC

12/17/2021 8:10:13 AM Merck KGaA : TEPMETKO Receives Positive CHMP Opinion For Patients With Advanced NSCLC

Merck Kgaa (MKGAY.PK)